Brief: Synact Pharma Appoints Malin Wikstrand As Interim CFO
19/01/2026 07:03
Jan 19 (Reuters) - SynAct Pharma AB SYNACT.ST: APPOINTS MALIN WIKSTRAND AS INTERIM CFO ROLE EFFECTIVE AS OF JANUARY 19, 2026 Source text: ID:nMFNyMQWj Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026